Scholars@Duke

Integrating GP IIb/IIIa inhibition into treatment strategies for acute ST-elevation myocardial infarction.

Publication ,  Journal Article
Kandzari, DE; Roe, MT
Published in: J Invasive Cardiol
September 2002
Link to item

Duke Scholars

Matthew Todd Roe
Author Matthew Todd Roe Medicine, Cardiology

Published In

J Invasive Cardiol

ISSN

1042-3931

Publication Date

September 2002

Volume

14

Issue

9

Start / End Page

565 / 574

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Thrombolytic Therapy
  • Syndrome
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Platelet Aggregation Inhibitors
  • Myocardial Infarction
  • Humans
  • Electrocardiography
  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kandzari, D. E., & Roe, M. T. (2002). Integrating GP IIb/IIIa inhibition into treatment strategies for acute ST-elevation myocardial infarction. J Invasive Cardiol, 14(9), 565–574.
Kandzari, David E., and Matthew T. Roe. “Integrating GP IIb/IIIa inhibition into treatment strategies for acute ST-elevation myocardial infarction.” J Invasive Cardiol 14, no. 9 (September 2002): 565–74.
Kandzari, David E., and Matthew T. Roe. “Integrating GP IIb/IIIa inhibition into treatment strategies for acute ST-elevation myocardial infarction.” J Invasive Cardiol, vol. 14, no. 9, Sept. 2002, pp. 565–74.

Published In

J Invasive Cardiol

ISSN

1042-3931

Publication Date

September 2002

Volume

14

Issue

9

Start / End Page

565 / 574

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Thrombolytic Therapy
  • Syndrome
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Platelet Aggregation Inhibitors
  • Myocardial Infarction
  • Humans
  • Electrocardiography
  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology